デフォルト表紙
市場調査レポート
商品コード
1630656

腎結石管理市場規模、シェア、成長分析、タイプ別、治療タイプ別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Kidney Stones Management Market Size, Share, Growth Analysis, By Type (Calcium Oxalate Stones, Uric Acid), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy), By Diagnosis, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
腎結石管理市場規模、シェア、成長分析、タイプ別、治療タイプ別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年
出版日: 2025年01月07日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腎結石管理の世界市場規模は2023年に20億6,000万米ドルと評価され、2024年の22億米ドルから2032年には37億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは7.0%で成長する見通しです。

世界の腎結石管理市場は、世界の腎臓結石症例の増加によって力強い成長を遂げています。回復を促進し、不快感を最小限に抑える衝撃波結石破砕術、尿管鏡検査、経皮的腎結石除去術などの先進技術を活用した革新的な治療オプションに対する需要が高まっています。市場は、レーザー結石破砕術やロボット支援手術を含む低侵襲技術への傾倒を強めており、正確な標的を確実に定めて患者の転帰を改善しています。さらに、再発防止や疼痛緩和を目的とした新薬の研究開発も進んでいます。高い普及率と支援的な費用償還政策により北米が優勢ではありますが、アジア太平洋地域は、ヘルスケア・インフラと認知度の向上に後押しされ、最も速い成長を示すと予測されます。全体として、この市場は技術の進歩と戦略的な地域拡大によって有望な軌道を描いています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術分析

腎結石管理市場規模:タイプ別

  • 市場概要
  • シュウ酸カルシウム結石
  • 尿酸
  • ストルバイト腎結石
  • シスチン結石
  • リン酸カルシウム結石

腎結石管理市場規模:治療タイプ別

  • 市場概要
  • 医薬品
  • 体外衝撃波結石破砕術
  • 尿管鏡検査
  • 経皮的腎結石摘出術

腎結石管理市場規模:診断別

  • 市場概要
  • 特殊超音波
  • 静脈性腎盂造影検査
  • CTスキャン
  • X線
  • その他

腎結石管理市場規模:エンドユーザー別

  • 市場概要
  • 病院
  • 専門クリニック
  • 外来手術センター

腎結石管理市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Boston Scientific Corporation(United States)
  • Olympus Corporation(Japan)
  • KARL STORZ SE & Co. KG(Germany)
  • Cook Medical Inc.(United States)
  • Dornier MedTech GmbH(Germany)
  • Richard Wolf GmbH(Germany)
  • Stryker Corporation(United States)
  • Siemens Healthineers AG(Germany)
  • Becton, Dickinson and Company(BD)(United States)
  • Coloplast A/S(Denmark)
  • DirexGroup(United States)
  • Storz Medical AG(Switzerland)
  • Allengers Medical Systems Ltd(India)
  • C.R. Bard Inc.(United States)
  • EDAP TMS(France)
  • Convergent Laser Technologies(United States)
  • HealthTronics, Inc.(United States)
  • United Medical Systems(DE), Inc.(United States)
  • Advanced MedTech Holdings(Singapore)
  • Calyxo, Inc.(United States)

結論と推奨事項

目次
Product Code: SQMIG35D2135

Global Kidney Stones Management Market size was valued at USD 2.06 billion in 2023 and is poised to grow from USD 2.2 billion in 2024 to USD 3.79 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The Global Kidney Stones Management Market is experiencing robust growth, driven by a rising incidence of kidney stone cases globally. There is an escalating demand for innovative treatment options, leveraging advanced technologies like shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy that enhance recovery and minimize discomfort. The market is increasingly leaning towards minimally invasive techniques, including laser lithotripsy and robotic-assisted surgeries, which ensure precise targeting and improved patient outcomes. Additionally, substantial research and development efforts are yielding new pharmaceuticals aimed at preventing recurrence and alleviating pain. Dominated by North America due to high prevalence and supportive reimbursement policies, the Asia-Pacific region is predicted to exhibit the fastest growth, propelled by enhanced healthcare infrastructure and awareness. Overall, this market demonstrates a promising trajectory marked by technological advancement and strategic regional expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Kidney Stones Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Kidney Stones Management Market Segmental Analysis

Global Kidney Stones Management Market is segmented by Type, Treatment Type, Diagnosis, End User and region. Based on Type, the market is segmented into Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones and Calcium Phosphate Stones. Based on Treatment Type, the market is segmented into Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy and Percutaneous Nephrolithotomy. Based on Diagnosis, the market is segmented into Specialty Ultrasound, Intravenous Pyelography, CT Scan, X-Ray and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Kidney Stones Management Market

A major driver of the Global Kidney Stones Management Market is the escalating incidence of kidney stone cases across the globe. The rising number of individuals affected by this condition is creating an urgent need for effective treatment solutions, thereby fueling advancements in medical technology and innovative procedures. As more people face challenges related to kidney stones, there is heightened attention towards research and development to enhance current treatment methodologies and unveil new interventions. This growing prevalence not only highlights the necessity for better management options but also propels market expansion as healthcare providers strive to meet the increasing demand for reliable kidney stone therapies.

Restraints in the Global Kidney Stones Management Market

A significant challenge facing the Global Kidney Stones Management Market is the elevated costs linked to specific treatment procedures and technologies. Although advanced options, like robotic-assisted surgeries and laser lithotripsy, provide substantial advantages in precision and patient outcomes, their high price can be prohibitive. Furthermore, many of these advanced treatments may lack availability or insurance coverage in certain areas, restricting access for patients with limited financial means. This financial barrier can impede the broader acceptance and implementation of advanced treatment methods, consequently affecting the overall growth potential of the market.

Market Trends of the Global Kidney Stones Management Market

The Global Kidney Stones Management market is witnessing a significant trend towards the increasing adoption of robotic-assisted surgeries for kidney stone removal. Innovations in robotic platforms, like Ethicon's MONARCH system, are becoming increasingly favored in urology for their precision and ability to minimize procedural complications. By integrating advanced robotic technologies, surgeons can execute more accurate and controlled maneuvers, which leads to improved patient outcomes and decreased rates of retreatment. This trend underscores the industry's commitment to harnessing cutting-edge technology, enhancing the overall efficacy and safety of kidney stone management procedures, and ultimately transforming patient care in this field.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technology Analysis

Global Kidney Stones Management Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

Global Kidney Stones Management Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

Global Kidney Stones Management Market Size by Diagnosis & CAGR (2025-2032)

  • Market Overview
  • Specialty Ultrasound
  • Intravenous Pyelography
  • CT Scan
  • X-Ray
  • Others

Global Kidney Stones Management Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Global Kidney Stones Management Market Size & CAGR (2025-2032)

  • North America (Type, Treatment Type, Diagnosis, End User)
    • US
    • Canada
  • Europe (Type, Treatment Type, Diagnosis, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Treatment Type, Diagnosis, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Treatment Type, Diagnosis, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Treatment Type, Diagnosis, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Boston Scientific Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • KARL STORZ SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dornier MedTech GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Richard Wolf GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DirexGroup (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Storz Medical AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allengers Medical Systems Ltd (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.R. Bard Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EDAP TMS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Convergent Laser Technologies (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthTronics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • United Medical Systems (DE), Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced MedTech Holdings (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Calyxo, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations